While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

NVO's fourth-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially ...

Although Novo Nordisk and Eli Lilly are the main players in the GLP-1 arena, a number of other pharmaceutical companies are ...

Novo Nordisk stock falls as Medicare selects its marketed semaglutide medicines catering to T2D and obesity for price negotiations in 2025.

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY, rose 3% and 2.3% on Tuesday, respectively, after results from a study ...

It is aimed at those with type 2 diabetes. How is it taken? Unlike Ozempic and Wegovy, Rybelsus is taken in the form of a tablet, once a day. Diabetes UK recommends taking it with an empty stomach, ...

Branded Wegovy and Zepbound normally cost $800 to ... while some are skeptical of GLP-1s but could use dissolvable tablets as a ramp-on product toward branded GLP-1s. Offering another form of ...

Wegovy and another drug called Mounjaro can ... there could be 20 weight-loss drugs on the market, including some in tablet form. As more effective and cheaper drugs become available, they could ...